Litcius/Paper detail

Combination of p38 MAPK inhibitor with PD-L1 antibody effectively prolongs survivals of temozolomide-resistant glioma-bearing mice via reduction of infiltrating glioma-associated macrophages and PD-L1 expression on resident glioma-associated microglia

Weiqi Dang, Jingfang Xiao, Qinghua Ma, Jingya Miao, Mianfu Cao, Lu Chen, Yu Shi, Xiaohong Yao, Shichang Yu, Xindong Liu, You‐Hong Cui, Xia Zhang, Xiuwu Bian

2021Brain Tumor Pathology26 citationsDOI

Topics & Concepts

TemozolomideGliomaMicrogliaMedicineCancer researchImmunotherapyCombination therapyIntegrin alpha MImmunologyPharmacologyImmune systemInflammationGlioma Diagnosis and TreatmentImmune cells in cancerCancer Immunotherapy and Biomarkers